|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||81.96 - 82.34|
|52 Week Range||66.72 - 92.97|
|PE Ratio (TTM)||11.35|
|Dividend & Yield||3.30 (3.39%)|
|1y Target Est||N/A|
Late last week, Biogen (BIIB) and six other pharma and biotech stocks were in the news due to the pricing of their multiple sclerosis ("MS") drugs.
Sanofi Pasteur, Sanofi’s (SNY) human vaccine business, reported 26.2% revenue growth at constant exchange rates to 1.0 billion euros in 2Q17. Sanofi Pasteur reported growth across all product franchises ...
Sanofi’s (SNY) generic business contributed ~5.1% of its total revenue in 2Q17. The business reported revenue of 442 million euros in 2Q17, an 8% decrease from 2Q16. Revenue fell due…